IGF-binding protein-2 protects against the development of obesity and insulin resistance - Test2 - elhamkhani - TriplyDB

IGF-binding protein-2 protects against the development of obesity and insulin resistance

IGF-binding protein-2 protects against the development of obesity and insulin resistance

http://www.wikidata.org/entity/Q34966710

about

Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial Ablation of the ID2 gene results in altered circadian feeding behavior, and sex-specific enhancement of insulin sensitivity and elevated glucose uptake in skeletal muscle and brown adipose tissue Insulin-like growth factor-1 deficiency and metabolic syndrome Transcriptional profiling of rats subjected to gestational undernourishment: implications for the developmental variations in metabolic traits The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice.Transcriptional regulatory program in wild-type and retinoblastoma gene-deficient mouse embryonic fibroblasts during adipocyte differentiation.Defining the pathway to insulin-like growth factor system targeting in cancer.The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women Body composition and gene expression QTL mapping in mice reveals imprinting and interaction effects.Integrative analysis using module-guided random forests reveals correlated genetic factors related to mouse weight.The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton Is there more to aging than mitochondrial DNA and reactive oxygen species?Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I).Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes.IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.IGFBP-2 - taking the lead in growth, metabolism and cancer Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast The IGF-I regulatory system and its impact on skeletal and energy homeostasis Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.CD36-deficient congenic strains show improved glucose tolerance and distinct shifts in metabolic and transcriptomic profiles Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.Regularization Methods for High-Dimensional Instrumental Variables Regression With an Application to Genetical Genomics.Igfbp2 Deletion in Ovariectomized Mice Enhances Energy Expenditure but Accelerates Bone Loss.Insulin-like growth factor axis and risk of type 2 diabetes in women Dissociation of somatic growth, time of sexual maturity, and life expectancy by overexpression of an RGD-deficient IGFBP-2 variant in female transgenic mice.Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states.Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton.The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.The role of liver-derived insulin-like growth factor-I.Metabolic phenotyping of a model of adipocyte differentiation.Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study.

P2860

Q21559684-03297D89-7642-4E9C-95FA-E2CCB002D094 Q27308124-D57AC48D-A436-440C-B43A-A2D45416B504 Q28072410-D4DD3575-5EF4-4035-8804-D5A845269EF6 Q28476257-583E7C31-5EA5-45C9-902B-48000C32A2BD Q28508627-4FC9D132-67E2-4A09-9BE2-140DCFABB3F7 Q31049602-F0602EF4-01AE-4E8F-B2E2-B4244D54B721 Q33594216-C2C5B0F3-D461-4A94-BF07-8330AA78913D Q33680916-CA0C8BCB-B8A6-4492-9D49-A710E89BA67B Q33912962-B509502B-97FA-4358-8CF6-C019EC676A48 Q34107722-63C01FEA-151D-4A4E-968C-1F6875756895 Q34127704-2F20E998-7074-4C66-BBCE-BE32A0EEB74E Q34310978-90F6F702-F101-49FB-B9B7-183BEA60CF78 Q34519459-5B53CB94-D58A-4C1D-AD3C-27D5B877361D Q34625338-F048B399-4552-4F69-A7EA-3C6579C6BA15 Q34800544-C2EA1E0F-4569-4629-9ABE-CD14D14365A8 Q34991091-A495B581-0B34-439F-B7D5-BFC430A66171 Q35010965-AFA31ED1-A6CF-4136-A0E8-97C883CC9493 Q35146163-7A7E44D2-87C9-42D0-9C9C-B84805836B78 Q35230193-A70097C5-2CE2-4283-8EB3-9C36A6251D27 Q35690618-1B512872-9985-4CC4-8F57-8C06515F8359 Q35690628-5112509C-4D1E-429B-9374-20E3E722E465 Q35729809-C018371E-C121-4F74-9276-5E9ECF6BD278 Q35747222-B65B115D-F04D-4A4F-9D96-CD5150BC76D6 Q35857746-BE0DF2C0-1CBB-48C1-96D4-9FF3A8B89D2A Q36029231-198A1971-EE66-449C-9B68-CE5F78688664 Q36032781-DDAC3B21-0178-476B-A2DD-C7CDB898D5BF Q36064698-9611B9B1-AEF8-40E7-80F4-6FB7DCE79224 Q36069805-C075D232-04FE-4E44-9735-867F46DDCCDF Q36164356-63753060-BCE5-467D-BC2E-84FED1B8BD96 Q36182551-337EAD53-F093-445B-BF77-DFA531ED47C7 Q36475243-5F55BB9E-F623-4E10-9528-1A234E684D6B Q36593819-1E9AECF3-CB7C-41A9-BABE-32032091231A Q36724703-95457DAB-5F2B-46BD-977A-B5F54406B310 Q36765385-1DE0E5CF-BC4A-4AAA-AB11-BEBB856F2A94 Q36990184-ED54680C-46FA-408A-8056-081E5B3B726F Q37018548-5C56A75E-E900-4DF0-8CFC-2D44B7F1BAFB Q37240147-2FB8DDDC-90E3-4660-A819-8308633132EC Q37381848-A116ACAC-5515-4D31-9577-C19F9A6727B7 Q37394769-84588BED-A674-479D-820F-A8DFD03D6DED Q37408256-3B90D810-9960-456B-91A9-92ED7DA67FDD

P2860

IGF-binding protein-2 protects against the development of obesity and insulin resistance

http://www.wikidata.org/entity/Q34966710

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@ast

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en-gb

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@nl

type

label

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@ast

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en-gb

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@nl

prefLabel

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@ast

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en-gb

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@nl

P1433

Q34966710-46C0486D-AA0C-4A13-ADD9-040E2E14250A

P1476

Q34966710-A48C8BF1-1D0B-4DD5-AEF0-755D868872C4

P2093

Q34966710-2A79A650-E757-4849-8018-5067C0C4A66B

Q34966710-7B7F1CAA-3A9A-4DD8-ACD0-5884F7895700

Q34966710-903971B3-49FD-4E8D-B3A2-14080AB2DE7C

Q34966710-9D3C1847-9A10-4FE7-A41F-E5736466D976

Q34966710-B4C9813E-31FA-4CA0-AA42-A99695E50B72

Q34966710-B560E554-0517-411C-97C7-B810BBEAFFA8

P2860

Q34966710-06783F44-1921-42B8-AF13-C418B95A4BB9

Q34966710-10940663-00A9-450E-AA97-9EE694E6BEAB

Q34966710-20B69644-891E-40EF-89F6-890FC2385C69

Q34966710-23D21702-08EB-404A-A62C-2ED7708BFAE6

Q34966710-2CF49F6E-56EC-40B9-A073-44706E61A354

Q34966710-2E5F90DB-2270-41E5-B31A-D20E0355071B

Q34966710-35C0CC4A-A883-447A-B017-518B642B88E0

Q34966710-42B4AA79-0163-4882-B94F-221DD0285812

Q34966710-482109C2-15DF-4261-BDA0-FD76B98E0332

Q34966710-4F5ED4F5-6491-494F-AE34-0FAFE539EAC2

P304

Q34966710-1828EF81-88F1-42FF-8C8E-8A37853BD54F

P31

Q34966710-19830224-73A8-41F3-BF91-6A2C2031B329

P356

Q34966710-B9E371D7-D058-4662-A714-9CDB08633E09

P407

Q34966710-3F53C4F5-20B3-4711-B562-9C03FD7F92F6

P433

Q34966710-E9DDD09A-43CF-4461-8AE5-CC3DBF726595

P478

Q34966710-4A00F1DD-26F9-48D1-9701-94D5BA2949DD

P50

Q34966710-1C9C9768-36C9-4769-85C5-2A52E3F5D413

Q34966710-5370B475-37AB-4BE9-ABBD-97126F21F890

Q34966710-879B0939-84D9-4994-B403-30803B61E8E6

Q34966710-F96499D6-019D-4788-B639-72F9DA236C38

Q34966710-FB887198-F7B0-44E2-ABD2-192D6AE283BA

Q34966710-FE29C183-6AF5-45C1-B030-3A0C7BBF8339

P577

Q34966710-A3D22CA1-CAFC-4B8F-9C1D-835B71E24513

P5875

Q34966710-9E6CC79A-81EF-48D1-9114-26F3FEFEEF20

P698

Q34966710-6EB4A29D-6EAD-4800-912E-ADAF71DBABA7

P921

Q34966710-D49FF361-3CA4-49DD-91A6-EF69E87CBF30

Q34966710-FDB4FC76-93CB-498B-92CB-7F3D2B04695F

P932

Q34966710-31A3088A-434C-4143-BE6D-F460EAFDA731

P356

P1433

P1476

IGF-binding protein-2 protects against the development of obesity and insulin resistance

@en

P2093

Gema Medina-Gomez

http://www.w3.org/2001/XMLSchema#string

John R Miell

http://www.w3.org/2001/XMLSchema#string

Michael Modo

http://www.w3.org/2001/XMLSchema#string

Paul A Crossey

http://www.w3.org/2001/XMLSchema#string

Vivienne A Ezzat

http://www.w3.org/2001/XMLSchema#string

Will P Cawthorn

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Cellular actions of the insulin-like growth factor binding proteins

Structure and localization of the human insulin-like growth factor-binding protein 2 gene

Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice

Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)

Adipose tissue as an endocrine organ

Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation

Years of life lost due to obesity.

The biology of white adipocyte proliferation.

Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice.

P304

285-294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB06-0436

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Steven C. R. Williams

Stephen Wheatcroft

Jaswinder K. Sethi

Antonio Vidal-Puig

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6545498

http://www.w3.org/2001/XMLSchema#string

P698

17259371

http://www.w3.org/2001/XMLSchema#string

P921

P932

4295171

http://www.w3.org/2001/XMLSchema#string